Fingolimod Capsule
Product Images NDC 72865-257

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 72865-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph depicting the percentage of patients with three-month confirmed progression over time (days) for two treatment groups: Fingolimod 0.5 mg and placebo. The graph shows an increase in patient progression percentage for both groups, with the placebo group reaching approximately 24% and the Fingolimod group approximately 18% by around 720 days.*

FDA Label Image

Fingolimodcontainerlabel (Fingolimodcontainerlabel)

Fingolimod 0.5 mg capsules label from XLCare Pharmaceuticals Inc., NDC 72865-257. The label indicates 30 capsules per container, prescription use only. It includes storage instructions, manufacturer and distributor details, and a reminder for pharmacists to dispense the medication guide.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Fingolimod hydrochloride showing its molecular arrangement with alkyl chain, aromatic ring, amino, hydroxyl groups, and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.